Gilead Sciences Inc (GILD)
94.40
+0.45
(+0.48%)
USD |
NASDAQ |
Dec 26, 16:00
94.45
+0.05
(+0.05%)
After-Hours: 20:00
Gilead Sciences Research and Development Expense (Annual): 5.718B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Pfizer Inc | 10.68B |
Eli Lilly and Co | 9.313B |
Merck & Co Inc | 30.53B |
AbbVie Inc | 8.453B |
Amgen Inc | 4.784B |